Berry Global India Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 04-12-2024
- Paid Up Capital ₹ 4.43 Cr
as on 04-12-2024
- Company Age 3 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit -2586.98%
(FY 2023)
- Ebitda -2699.34%
(FY 2023)
- Net Worth -21.78%
(FY 2023)
- Total Assets 218.40%
(FY 2023)
About Berry Global India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 4.43 Cr, as per Ministry of Corporate Affairs (MCA) records.
Walid Hamza, Mark Miles, Jason Greene, and Two other members serve as directors at the Company.
- CIN/LLPIN
U25200KA2021FTC152314
- Company No.
152314
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
27 Sep 2021
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Berry Global India?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Walid Hamza  | Additional Director | 26-Mar-2024 | Current |
Mark Miles  | Additional Director | 26-Mar-2024 | Current |
| Jason Greene | Additional Director | 26-Mar-2024 | Current |
Joseph Eappachan  | Additional Director | Current | |
| Jasraj Singh | Director | 27-Sep-2021 | Current |
Financial Performance and Corporate Structure Insights of Berry Global India.
Berry Global India Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 2586.98% decrease in profit. The company's net worth observed a substantial decline by a decrease of 21.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Berry Global India?
In 2023, Berry Global India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bprex Pharma Packaging India Private LimitedActive 38 years 4 daysWalid Hamza, Mark Miles and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Berry Global India?
Berry Global India has a workforce of 38 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Berry Global India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Berry Global India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
